Regenxbio Inc buy BiotechBee
Start price
08.09.24
/
60%
€10.30
Target price
28.02.27
€16.00
Performance (%)
-22.82%
End price
14.12.24
€7.95
Summary
This prediction ended on 14.12.24 with a price of €7.95. The prediction for Regenxbio Inc disappointed with a performance of -22.82%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regenxbio Inc | -7.031% | -7.031% | 59.732% |
| iShares Core DAX® | 0.323% | 2.208% | 21.610% |
| iShares Nasdaq 100 | 0.145% | -0.987% | 5.603% |
| iShares Nikkei 225® | 0.091% | -1.421% | 12.897% |
| iShares S&P 500 | 0.371% | -0.469% | 3.470% |
According to BiotechBee what are the pros and cons of Regenxbio Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Regenxbio Inc diskutieren
Buy mit Kursziel 16,0